KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)DivestmentsDividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pfizer (PFE) Depreciation & Amortization (CF) (2016 - 2026)

Pfizer has reported Depreciation & Amortization (CF) over the past 18 years, most recently at $1.6 billion for Q1 2026.

  • Quarterly Depreciation & Amortization (CF) changed 0.31% to $1.6 billion in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $6.6 billion through Mar 2026, up 29.08% year-over-year, with the annual reading at $6.6 billion for FY2025, 6.0% down from the prior year.
  • Depreciation & Amortization (CF) was $1.6 billion for Q1 2026 at Pfizer, down from $1.7 billion in the prior quarter.
  • Over five years, Depreciation & Amortization (CF) peaked at $3.5 billion in Q4 2022 and troughed at $1.2 billion in Q3 2022.
  • The 5-year median for Depreciation & Amortization (CF) is $1.6 billion (2025), against an average of $1.7 billion.
  • The largest YoY upside for Depreciation & Amortization (CF) was 33.87% in 2023 against a maximum downside of 55.99% in 2023.
  • A 5-year view of Depreciation & Amortization (CF) shows it stood at $3.5 billion in 2022, then crashed by 52.89% to $1.7 billion in 2023, then increased by 5.09% to $1.8 billion in 2024, then decreased by 3.87% to $1.7 billion in 2025, then dropped by 4.39% to $1.6 billion in 2026.
  • Per Business Quant, the three most recent readings for PFE's Depreciation & Amortization (CF) are $1.6 billion (Q1 2026), $1.7 billion (Q4 2025), and $1.7 billion (Q3 2025).